GB9724544D0 - Novel Formulation - Google Patents

Novel Formulation

Info

Publication number
GB9724544D0
GB9724544D0 GBGB9724544.3A GB9724544A GB9724544D0 GB 9724544 D0 GB9724544 D0 GB 9724544D0 GB 9724544 A GB9724544 A GB 9724544A GB 9724544 D0 GB9724544 D0 GB 9724544D0
Authority
GB
United Kingdom
Prior art keywords
novel formulation
formulation
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9724544.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9724544.3A priority Critical patent/GB9724544D0/en
Publication of GB9724544D0 publication Critical patent/GB9724544D0/en
Priority to DZ980268A priority patent/DZ2658A1/xx
Priority to AU11680/99A priority patent/AU1168099A/en
Priority to EP98954631A priority patent/EP1033986A1/en
Priority to BR9814220-8A priority patent/BR9814220A/pt
Priority to PE1998001126A priority patent/PE20000381A1/es
Priority to JP2000521827A priority patent/JP2001523718A/ja
Priority to KR1020007005532A priority patent/KR20010032320A/ko
Priority to TR2000/01423T priority patent/TR200001423T2/xx
Priority to APAP/P/2000/001821A priority patent/AP2000001821A0/en
Priority to CN98811404A priority patent/CN1279608A/zh
Priority to HU0100580A priority patent/HUP0100580A3/hu
Priority to PCT/GB1998/003471 priority patent/WO1999026625A1/en
Priority to PL98340555A priority patent/PL340555A1/xx
Priority to SK734-2000A priority patent/SK7342000A3/sk
Priority to IL13610698A priority patent/IL136106A0/xx
Priority to EA200000552A priority patent/EA200000552A1/ru
Priority to ARP980105880A priority patent/AR015485A1/es
Priority to MA25357A priority patent/MA24704A1/fr
Priority to ZA9810637A priority patent/ZA9810637B/xx
Priority to CO98068459A priority patent/CO4970832A1/es
Priority to ARP990105880 priority patent/AR021323A2/es
Priority to OA1200000153A priority patent/OA11385A/en
Priority to NO20002590A priority patent/NO20002590L/no
Priority to BG104527A priority patent/BG104527A/xx
Priority to US09/925,354 priority patent/US20020032220A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
GBGB9724544.3A 1997-11-21 1997-11-21 Novel Formulation Ceased GB9724544D0 (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
GBGB9724544.3A GB9724544D0 (en) 1997-11-21 1997-11-21 Novel Formulation
EA200000552A EA200000552A1 (ru) 1997-11-21 1998-11-18 Готовые препаративные формы, содержащие растворенный пароксетин
PCT/GB1998/003471 WO1999026625A1 (en) 1997-11-21 1998-11-18 Formulations comprising dissolved paroxetine
SK734-2000A SK7342000A3 (en) 1997-11-21 1998-11-18 Formulations comprising dissolved paroxetine
EP98954631A EP1033986A1 (en) 1997-11-21 1998-11-18 Formulations comprising dissolved paroxetine
BR9814220-8A BR9814220A (pt) 1997-11-21 1998-11-18 Formulações compreendendo paroxetinadissolvida
PE1998001126A PE20000381A1 (es) 1997-11-21 1998-11-18 Nuevas formulaciones de paroxetina
JP2000521827A JP2001523718A (ja) 1997-11-21 1998-11-18 溶存パロキセチンを含む処方
KR1020007005532A KR20010032320A (ko) 1997-11-21 1998-11-18 용해된 파록세틴을 포함하는 제형
TR2000/01423T TR200001423T2 (tr) 1997-11-21 1998-11-18 Erimiş paroksetin içeren yeni formülasyonlar
APAP/P/2000/001821A AP2000001821A0 (en) 1997-11-21 1998-11-18 Formulations comprising dissolved paroxetine.
CN98811404A CN1279608A (zh) 1997-11-21 1998-11-18 含有溶解了帕罗西汀的制剂
HU0100580A HUP0100580A3 (en) 1997-11-21 1998-11-18 Formulations comprising dissolved paroxetine
DZ980268A DZ2658A1 (fr) 1997-11-21 1998-11-18 Formulations nouvelles de paroxétine et procédé pour leur préparation.
PL98340555A PL340555A1 (en) 1997-11-21 1998-11-18 Preparations containing dissolved paroxetin
AU11680/99A AU1168099A (en) 1997-11-21 1998-11-18 Formulations comprising dissolved paroxetine
IL13610698A IL136106A0 (en) 1997-11-21 1998-11-18 Formulations comprising dissolved paroxetine
MA25357A MA24704A1 (fr) 1997-11-21 1998-11-19 Formulations nouvelles de paroxetine et procede pour leur preparation
ARP980105880A AR015485A1 (es) 1997-11-21 1998-11-19 Una capsula oral tragable que contiene paroxetina, una forma solida de dosificacion oral tragable, una formulacion farmaceutica, una procedimiento parapreparar dicha formulacion y la utilizacion de paroxetina disuelta en un vehiculo para fabricar capsulas o formas solidas de dosificacion orales trag
ZA9810637A ZA9810637B (en) 1997-11-21 1998-11-20 Formulations comprising dissolved paroxetine.
CO98068459A CO4970832A1 (es) 1997-11-21 1998-11-20 Nuevas formulaciones y procesos para su fabricacion
ARP990105880 AR021323A2 (es) 1997-11-21 1999-11-18 Disposicion de monitoreo de lavado de tuberias de tambo
OA1200000153A OA11385A (en) 1997-11-21 2000-05-19 Formulations comprising dissolved paroxetine.
NO20002590A NO20002590L (no) 1997-11-21 2000-05-19 Formuleringer omfattende oppløst paroxetin
BG104527A BG104527A (en) 1997-11-21 2000-06-13 Formulations comprising dissolved paroxetine
US09/925,354 US20020032220A1 (en) 1997-11-21 2001-08-09 Formulations comprising dissolved paroxetine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9724544.3A GB9724544D0 (en) 1997-11-21 1997-11-21 Novel Formulation

Publications (1)

Publication Number Publication Date
GB9724544D0 true GB9724544D0 (en) 1998-01-21

Family

ID=10822374

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9724544.3A Ceased GB9724544D0 (en) 1997-11-21 1997-11-21 Novel Formulation

Country Status (24)

Country Link
EP (1) EP1033986A1 (no)
JP (1) JP2001523718A (no)
KR (1) KR20010032320A (no)
CN (1) CN1279608A (no)
AP (1) AP2000001821A0 (no)
AR (1) AR015485A1 (no)
AU (1) AU1168099A (no)
BG (1) BG104527A (no)
BR (1) BR9814220A (no)
CO (1) CO4970832A1 (no)
DZ (1) DZ2658A1 (no)
EA (1) EA200000552A1 (no)
GB (1) GB9724544D0 (no)
HU (1) HUP0100580A3 (no)
IL (1) IL136106A0 (no)
MA (1) MA24704A1 (no)
NO (1) NO20002590L (no)
OA (1) OA11385A (no)
PE (1) PE20000381A1 (no)
PL (1) PL340555A1 (no)
SK (1) SK7342000A3 (no)
TR (1) TR200001423T2 (no)
WO (1) WO1999026625A1 (no)
ZA (1) ZA9810637B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810180D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulation
EP1161241B1 (de) * 1999-03-12 2005-12-07 Aesica Pharmaceuticals Ltd. Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
ATE248165T1 (de) 1999-07-01 2003-09-15 Italfarmaco Spa Komplexe von paroxetin mit cyclodextrin oder cyclodextrin derivaten
DE19930454A1 (de) * 1999-07-02 2001-01-04 Knoll Ag Feste Paroxetin enthaltende Zubereitungen
US6720003B2 (en) 2001-02-16 2004-04-13 Andrx Corporation Serotonin reuptake inhibitor formulations
DE60222803T2 (de) * 2001-12-21 2008-07-17 Supernus Pharmaceuticals, Inc. Orale kapselformulierung mit verbesserter physikalischer stabilität
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
WO2006119779A2 (en) * 2005-05-10 2006-11-16 Lifecycle Pharma A/S A pharmaceutical composition comprising an aldosterone antagonist in form of solid solution
WO2011071194A1 (ko) * 2009-12-08 2011-06-16 주식회사 일화 20-O-β-D-글루코피라노실-20(S)-프로토파낙사디올을 포함하는 고체분산체
GB201020032D0 (en) * 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2216934A1 (en) * 1995-04-03 1996-10-10 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
KR20000070151A (ko) * 1997-01-15 2000-11-25 피터 기딩스 파록세틴 조성물

Also Published As

Publication number Publication date
DZ2658A1 (fr) 2003-03-22
BG104527A (en) 2001-04-30
HUP0100580A3 (en) 2002-05-28
EP1033986A1 (en) 2000-09-13
ZA9810637B (en) 2000-05-22
CN1279608A (zh) 2001-01-10
WO1999026625A1 (en) 1999-06-03
KR20010032320A (ko) 2001-04-16
AR015485A1 (es) 2001-05-02
TR200001423T2 (tr) 2000-10-23
NO20002590L (no) 2000-07-19
EA200000552A1 (ru) 2000-10-30
IL136106A0 (en) 2001-05-20
AP2000001821A0 (en) 2000-06-30
MA24704A1 (fr) 1999-07-01
CO4970832A1 (es) 2000-11-07
SK7342000A3 (en) 2000-12-11
JP2001523718A (ja) 2001-11-27
NO20002590D0 (no) 2000-05-19
AU1168099A (en) 1999-06-15
BR9814220A (pt) 2001-12-26
HUP0100580A2 (hu) 2002-04-29
OA11385A (en) 2004-01-27
PL340555A1 (en) 2001-02-12
PE20000381A1 (es) 2000-05-07

Similar Documents

Publication Publication Date Title
IL135295A0 (en) 2-methyl-thieno-benzodiazepine formulation
GB9715751D0 (en) Formulations
AP9500715A0 (en) Novel formulation
ZA9811461B (en) New formulation
HK1026889A1 (en) Novel aryloxy-alkyl-dialkylamines
ZA9710601B (en) Novel formulation
GB9715203D0 (en) Composition
PL335700A1 (en) Novel preparation
HK1026429A1 (en) New formulation
SI1036083T1 (en) Novel 9a-azalides
GB9713620D0 (en) Composition
GB9724544D0 (en) Novel Formulation
EP0958806A4 (en) HAIR COLORING COMPOSITION
ZA9810773B (en) Revitalisation formulation
GB9706957D0 (en) Formulation
GB9810180D0 (en) Novel formulation
GB9701031D0 (en) Composition
GB9615628D0 (en) Formulation
GB9721807D0 (en) Formulation
GB9725275D0 (en) Formulation
PL318601A1 (en) Novel 5-arylidene-4-oxo-2-imidazpglycines
GB9705110D0 (en) Composition
GB9818910D0 (en) Novel formulation
GB9818905D0 (en) Novel formulation
EG23068A (en) Pesticidale composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)